Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

rhenium Re 186 etidronate

An synthetic compound containing the organic phosphonate hydroxyethylidene diphosphonate (HEDP) labeled with the radioisotope rhenium Re 186. Re-186 etidronate binds to hydroxyapatite in bone, delivering a cytotoxic dose of beta radiation to primary and metastatic bone tumors. Re-186 is a beta emitter with a short half-life, a radioisotope profile that provides localized antitumor radiocytotoxicity while sparing extramedullary bone marrow tissues.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:186Re-etidronate
Re 186 hydroxyethylidene diphosphonate
Re-186 hydroxyethylidene diphosphonate
rhenium Re-186 hydroxyethylidene diphosphonate
rhenium-186 HEDP
Abbreviation:Re-186 HEDP
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search